MEDIROM Healthcare Technologies
MRM
4 hedge funds and large institutions have $1.13M invested in MEDIROM Healthcare Technologies in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 2 → 4 (+2)
11% more capital invested
Capital invested by funds: $1.02M → $1.13M (+$113K)
0.58% more ownership
Funds ownership: 1.47% → 2.05% (+0.58%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$248K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$129K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$7.15K |
MRM Hedge Fund Activity: Q1 2021 in Review
4 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in MEDIROM Healthcare Technologies (MRM) for Q1 2021, worth a combined $1.13M — up 11% from $1.02M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new MRM positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $248K. The largest seller was UBS Group, cutting an estimated $7.15K.
- 4 institutional investors held MEDIROM Healthcare Technologies (MRM) as of Q1 2021, up from 2 in Q4 2020.
- Funds reported $1.13M of MEDIROM Healthcare Technologies stock for Q1 2021, up 11% quarter-over-quarter.
- 2 funds opened new MEDIROM Healthcare Technologies positions in Q1 2021 and 0 closed out, a net change of +2 holders.
- The largest MEDIROM Healthcare Technologies buyer in Q1 2021 was Citadel Advisors, an estimated $248K added.
- The largest MEDIROM Healthcare Technologies seller in Q1 2021 was UBS Group, an estimated $7.15K sold.
Based on aggregated 13F filings for Q1 2021.